Various healthcare companies are already implementing high-tech solutions into existing healthcare systems.
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
A total of 889 M&A deals were announced in the medical devices sector in 2022 worth $93 billion
The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021
The supplemental New Drug Application is based on results from the landmark EMPA-KIDNEY phase III trial
AI-based medical imaging equipment firm Lunit has signed a contract to supply AI-based breast cancer screening solution “Lunit Insight MMG”
More women centric initiatives being the need of the hour for holistic development
Dapagliflozin reduces the risk of sustained eGFR, cardiovascular deaths and hospitalization for heart failure in adults with CKD
The receipt of this permission paves way for the launch of Dapagliflozin (Forxiga) tablets of 10 mg in India for the specified additional/expanded indication, subject to the receipt of related statutory approvals
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
Subscribe To Our Newsletter & Stay Updated
